FAQ/Help |
Calendar |
Search |
Today's Posts |
07-23-2013, 11:44 AM | #1 | ||
|
|||
Member
|
Biogen has applled for trials in Europe and America for its new Beta-Interferon drug Plegridy. It will require only monthly injections, fewer than Avonex.
I was unable to take Alpha-Interferon for my Polycythemia Vera, so I am not not sanguine about this for MS, but it should be mentioned. Maybe someone else has already mentioned it. |
||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
Beta interferon has not proven it stops disability progression | Multiple Sclerosis | |||
Biogen tapping into oral MS drug market | Multiple Sclerosis |